Hugues Meyrath, President, CEO & Director, highlighted that "revenue at the high end of our guidance range. Non-GAAP operating expenses, $5 million lower from the prior quarter and positive adjusted ...
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce its financial and operational results for the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results